Massachusetts–based startup TransMolecular announced in recent weeks that it had completed a phase 1 trial of its radiolabeled synthetic analog of the scorpion venom peptide chlorotoxin (131 I ...

Chimeric Therapeutics Ltd is a biotechnology company engaged in developing a cancer cell therapy drug. Its technology CLTX-CAR T uses chlorotoxin, a peptide discovered in scorpion venom, as the ...

Background: Single photon emission computed tomography (SPECT) is becoming increasingly popular in oncology. This study endeavors to scrutinize the radiation protection knowledge, attitude, and ...